SA
LLY icon

SRN Advisors’s Eli Lilly LLY Stock Holding History

SRN Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$841K Buy
1,079
+17
+2% +$13.2K 0.77% 51
2025
Q1 		$877K Sell
1,062
-24
-2% -$20K 0.99% 35
2024
Q4 		$838K Buy
+1,086
New +$899K 0.75% 66

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SRN Advisors's LLY Position: Q2 2025 in Review

SRN Advisors increased its Eli Lilly (LLY) stake by 1.6% in Q2 2025, buying an estimated $13.2K and bringing the position to 1,079 shares worth $841K. The position accounts for 0.77% of the portfolio, ranked #51.

SRN Advisors first reported a position in LLY in Q4 2024 and has held it in 3 quarters since. The position peaked at $877K in Q1 2025. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • SRN Advisors held 1,079 shares of Eli Lilly worth $841K as of Q2 2025.
  • SRN Advisors bought 17 Eli Lilly shares in Q2 2025, an estimated $13.2K.
  • Eli Lilly made up 0.77% of SRN Advisors's portfolio in Q2 2025, its #51 holding.
  • SRN Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 3 quarters since.
  • SRN Advisors's Eli Lilly position peaked at $877K in Q1 2025.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on SRN Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.